# Ablation of Paroxysmal Atrial Fibrillation Using the Appropriate Contact Force in a Chinese Population

Study · id `cardio:ct-nct02493075` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02493075](<https://clinicaltrials.gov/study/NCT02493075>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02493075

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 140 participants.

## Technical summary

Registry record NCT02493075. Randomized; single masking; primary purpose screening. Start 2015-03 (registry gives no type); primary completion 2018-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose screening
- Phase: Phase 1/2
- Enrolled: 140 participants (planned count; ClinicalTrials.gov record NCT02493075, source copy `cardio:ctgov-nct02493075-2015-07-09`, retrieved 2026-10-26)
- Start date: 2015-03 (registry gives no type) (ClinicalTrials.gov record NCT02493075, source copy `cardio:ctgov-nct02493075-2015-07-09`, retrieved 2026-10-26)
- Primary completion: 2018-01 (anticipated) (ClinicalTrials.gov record NCT02493075, source copy `cardio:ctgov-nct02493075-2015-07-09`, retrieved 2026-10-26)
- Completion: 2018-06 (anticipated) (ClinicalTrials.gov record NCT02493075, source copy `cardio:ctgov-nct02493075-2015-07-09`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02493075, source copy `cardio:ctgov-nct02493075-2015-07-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02493075-2015-07-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Ablation of Paroxysmal Atrial Fibrillation Using the Appropriate Contact Force in a Chinese Population
- Condition: Atrial Fibrillation
- Intervention (Behavioral): The operator blinded to the contact force data or not.
- Lead sponsor: Sir Run Run Shaw Hospital
- Lead sponsor class: OTHER
- Collaborator: Biosense Webster, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Sir Run Run Shaw Hospital (`cardio:org-sir-run-run-shaw-hospital`)
- Registry lists this organization as a collaborator: Biosense Webster, Inc. (`cardio:org-biosense-webster-inc`)

## Provenance

Content hash: a193f9f05d1f495083507dcc347142242fa8a37ec90a2d3824aef23c2985462a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
